News | December 07, 2023
Dr. Reddy's inks pact with Coya Therapeutics for development of sclerosis drug
Dr. Reddy's will make a US$ 7.5 million upfront payment to Coya
Dr. Reddy's will make a US$ 7.5 million upfront payment to Coya
The full transition of Viatris' biosimilars operations to Biocon Biologics in Europe represents another significant milestone
South Asia’s largest Trade Fair for pharma brought together over 50,000 visitors from across the globe, more than 1,500 exhibitors showcasing 10,000+ products and representation from over 80 countries
The divestment is a part of Fortis' ongoing portfolio rationalization strategy
Acquisition underscores Merck’s ongoing commitment to developing treatments for neurodegenerative diseases
Emphasizes the need for a collective effort on bolstering resilience across economies, societies, healthcare systems, education systems and infrastructure
Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain
This collaboration underscores WOTR's unwavering commitment to strengthening rural communities against the unpredictable variations of climate change
We are redesigning Bayer to focus only on what’s essential for our mission, ‘Health for all, hunger for none’”
The companies plan to start a pivotal Phase 3 trial in the coming months
Subscribe To Our Newsletter & Stay Updated
